781 related articles for article (PubMed ID: 29653926)
1. Inhibiting Fibronectin Attenuates Fibrosis and Improves Cardiac Function in a Model of Heart Failure.
Valiente-Alandi I; Potter SJ; Salvador AM; Schafer AE; Schips T; Carrillo-Salinas F; Gibson AM; Nieman ML; Perkins C; Sargent MA; Huo J; Lorenz JN; DeFalco T; Molkentin JD; Alcaide P; Blaxall BC
Circulation; 2018 Sep; 138(12):1236-1252. PubMed ID: 29653926
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological and Activated Fibroblast Targeting of Gβγ-GRK2 After Myocardial Ischemia Attenuates Heart Failure Progression.
Travers JG; Kamal FA; Valiente-Alandi I; Nieman ML; Sargent MA; Lorenz JN; Molkentin JD; Blaxall BC
J Am Coll Cardiol; 2017 Aug; 70(8):958-971. PubMed ID: 28818206
[TBL] [Abstract][Full Text] [Related]
3. Fibronectin inhibitor pUR4 attenuates tumor necrosis factor α-induced endothelial hyperpermeability by modulating β1 integrin activation.
Lee TH; Hsieh ST; Chiang HY
J Biomed Sci; 2019 May; 26(1):37. PubMed ID: 31096970
[TBL] [Abstract][Full Text] [Related]
4. Soluble guanylyl cyclase activation improves progressive cardiac remodeling and failure after myocardial infarction. Cardioprotection over ACE inhibition.
Fraccarollo D; Galuppo P; Motschenbacher S; Ruetten H; Schäfer A; Bauersachs J
Basic Res Cardiol; 2014 Jul; 109(4):421. PubMed ID: 24907870
[TBL] [Abstract][Full Text] [Related]
5. A novel fibroblast activation inhibitor attenuates left ventricular remodeling and preserves cardiac function in heart failure.
Bradley JM; Spaletra P; Li Z; Sharp TE; Goodchild TT; Corral LG; Fung L; Chan KWH; Sullivan RW; Swindlehurst CA; Lefer DJ
Am J Physiol Heart Circ Physiol; 2018 Sep; 315(3):H563-H570. PubMed ID: 29949382
[TBL] [Abstract][Full Text] [Related]
6. Recombinant Human ADAMTS13 Treatment Improves Myocardial Remodeling and Functionality After Pressure Overload Injury in Mice.
Witsch T; Martinod K; Sorvillo N; Portier I; De Meyer SF; Wagner DD
J Am Heart Assoc; 2018 Jan; 7(3):. PubMed ID: 29367415
[TBL] [Abstract][Full Text] [Related]
7. Moderate Loss of the Extracellular Matrix Proteoglycan Lumican Attenuates Cardiac Fibrosis in Mice Subjected to Pressure Overload.
Mohammadzadeh N; Melleby AO; Palmero S; Sjaastad I; Chakravarti S; Engebretsen KVT; Christensen G; Lunde IG; Tønnessen T
Cardiology; 2020; 145(3):187-198. PubMed ID: 31968347
[TBL] [Abstract][Full Text] [Related]
8. Intercellular Adhesion Molecule 1 Regulates Left Ventricular Leukocyte Infiltration, Cardiac Remodeling, and Function in Pressure Overload-Induced Heart Failure.
Salvador AM; Nevers T; Velázquez F; Aronovitz M; Wang B; Abadía Molina A; Jaffe IZ; Karas RH; Blanton RM; Alcaide P
J Am Heart Assoc; 2016 Mar; 5(3):e003126. PubMed ID: 27068635
[TBL] [Abstract][Full Text] [Related]
9. Anti-remodeling and anti-fibrotic effects of the neuregulin-1β glial growth factor 2 in a large animal model of heart failure.
Galindo CL; Kasasbeh E; Murphy A; Ryzhov S; Lenihan S; Ahmad FA; Williams P; Nunnally A; Adcock J; Song Y; Harrell FE; Tran TL; Parry TJ; Iaci J; Ganguly A; Feoktistov I; Stephenson MK; Caggiano AO; Sawyer DB; Cleator JH
J Am Heart Assoc; 2014 Oct; 3(5):e000773. PubMed ID: 25341890
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of fibronectin deposition improves experimental liver fibrosis.
Altrock E; Sens C; Wuerfel C; Vasel M; Kawelke N; Dooley S; Sottile J; Nakchbandi IA
J Hepatol; 2015 Mar; 62(3):625-33. PubMed ID: 24946284
[TBL] [Abstract][Full Text] [Related]
11. Antifibrotic cardioprotection of berberine via downregulating myocardial IGF-1 receptor-regulated MMP-2/MMP-9 expression in diabetic rats.
Li G; Xing W; Zhang M; Geng F; Yang H; Zhang H; Zhang X; Li J; Dong L; Gao F
Am J Physiol Heart Circ Physiol; 2018 Oct; 315(4):H802-H813. PubMed ID: 29957017
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of fibronectin polymerization alleviates kidney injury due to ischemia-reperfusion.
Bowers SLK; Davis-Rodriguez S; Thomas ZM; Rudomanova V; Bacon WC; Beiersdorfer A; Ma Q; Devarajan P; Blaxall BC
Am J Physiol Renal Physiol; 2019 Jun; 316(6):F1293-F1298. PubMed ID: 31017009
[TBL] [Abstract][Full Text] [Related]
13. A novel mtDNA repair fusion protein attenuates maladaptive remodeling and preserves cardiac function in heart failure.
Bradley JM; Li Z; Organ CL; Polhemus DJ; Otsuka H; Islam KN; Bhushan S; Gorodnya OM; Ruchko MV; Gillespie MN; Wilson GL; Lefer DJ
Am J Physiol Heart Circ Physiol; 2018 Feb; 314(2):H311-H321. PubMed ID: 29101177
[TBL] [Abstract][Full Text] [Related]
14. PEGylated pUR4/FUD peptide inhibitor of fibronectin fibrillogenesis decreases fibrosis in murine Unilateral Ureteral Obstruction model of kidney disease.
Tomasini-Johansson BR; Zbyszynski PW; Toraason I; Peters DM; Kwon GS
PLoS One; 2018; 13(10):e0205360. PubMed ID: 30356276
[TBL] [Abstract][Full Text] [Related]
15. Bone Morphogenetic Protein 9 Reduces Cardiac Fibrosis and Improves Cardiac Function in Heart Failure.
Morine KJ; Qiao X; York S; Natov PS; Paruchuri V; Zhang Y; Aronovitz MJ; Karas RH; Kapur NK
Circulation; 2018 Jul; 138(5):513-526. PubMed ID: 29487140
[TBL] [Abstract][Full Text] [Related]
16. Raf kinase inhibitor protein mediates myocardial fibrosis under conditions of enhanced myocardial oxidative stress.
Kazakov A; Hall RA; Werner C; Meier T; Trouvain A; Rodionycheva S; Nickel A; Lammert F; Maack C; Böhm M; Laufs U
Basic Res Cardiol; 2018 Sep; 113(6):42. PubMed ID: 30191336
[TBL] [Abstract][Full Text] [Related]
17. Human Endomyocardial Biopsy Specimen-Derived Stromal Cells Modulate Angiotensin II-Induced Cardiac Remodeling.
Miteva K; Van Linthout S; Pappritz K; Müller I; Spillmann F; Haag M; Stachelscheid H; Ringe J; Sittinger M; Tschöpe C
Stem Cells Transl Med; 2016 Dec; 5(12):1707-1718. PubMed ID: 27460853
[TBL] [Abstract][Full Text] [Related]
18. MiR-155 Knockout in Fibroblasts Improves Cardiac Remodeling by Targeting Tumor Protein p53-Inducible Nuclear Protein 1.
He W; Huang H; Xie Q; Wang Z; Fan Y; Kong B; Huang D; Xiao Y
J Cardiovasc Pharmacol Ther; 2016 Jul; 21(4):423-35. PubMed ID: 26589288
[TBL] [Abstract][Full Text] [Related]
19. HMGCoA reductase inhibition reverses myocardial fibrosis and diastolic dysfunction through AMP-activated protein kinase activation in a mouse model of metabolic syndrome.
Hermida N; Markl A; Hamelet J; Van Assche T; Vanderper A; Herijgers P; van Bilsen M; Hilfiker-Kleiner D; Noppe G; Beauloye C; Horman S; Balligand JL
Cardiovasc Res; 2013 Jul; 99(1):44-54. PubMed ID: 23542580
[TBL] [Abstract][Full Text] [Related]
20. A77 1726 (leflunomide) blocks and reverses cardiac hypertrophy and fibrosis in mice.
Ma ZG; Zhang X; Yuan YP; Jin YG; Li N; Kong CY; Song P; Tang QZ
Clin Sci (Lond); 2018 Mar; 132(6):685-699. PubMed ID: 29540538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
